VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
EQEquillium, Inc.$2.81$271M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksEQRevenue History

EQ logoEquillium, Inc. (EQ) Revenue History

Annual and quarterly revenue from 2017 to present

TTM Revenue$0
YoY Growth—
Q1 2026$0
Revenue CAGR
3Y—
→
5Y—
→
10Y—
Best Fiscal Year$41.1M (2024)
Best Quarter$15.8M (Q4 2022)

EQ Revenue Over Time (2017–2025)

EQ Revenue Growth History

2 of 3 years with positive growth
Annual Revenue Growth · Each cell = one fiscal year
2017—
2018—
2019—
2020—
2021—
2022—
2023+129.0%
2024+13.9%
2025-100.0%
FY2017 revenue growth
N/A
FY2018 revenue growth
N/A
FY2019 revenue growth
N/A
FY2020 revenue growth
N/A
FY2021 revenue growth
N/A
FY2022 revenue growth
N/A
FY2023 revenue growth
+129.0%
FY2024 revenue growth
+13.9%
FY2025 revenue growth
-100.0%
DeclineStrong growth
↓ 1-year revenue declineBest: +129.0% (FY2023)Worst: -100.0% (FY2025)
Recent Quarterly Revenue & YoY Growth
QuarterRevenueYoY
Q1 2026$0—
Q4 2025$0-100.0%
Q3 2025$0-100.0%
Q2 2025$0-100.0%
Q1 2025$0-100.0%
Q4 2024$4.4M-52.3%
Q3 2024$12.2M+37.1%
Q2 2024$13.9M+51.8%
Seasonal Revenue Pattern (fiscal quarters)
Q1
17%
Q2
20%
Q3
18%
Q4
45%

Multi-year avg. share of annual revenue by fiscal quarter

EQ Revenue Analysis (2017–2025)

Current Revenue & Growth

As of June 12, 2026, Equillium, Inc. (EQ) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue

Historical Growth Trajectory

EQ's historical revenue data shows various trends over time. Equillium, Inc.'s highest annual revenue of $41.1 million was recorded in 2024.

Peer Comparison

Compared to Healthcare sector peers — including ARQT (+95.3% YoY), and KMDA (+8.6% YoY). Compare EQ vs ARQT →

EQ Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
EQ logoEQCurrent$0---
ARQT logoARQT$376M+95.3%--3.3%
KMDA logoKMDA$180M+8.6%+6.3%14.5%
Best in groupLowest in group

EQ Historical Revenue Data (2017–2025)

1–9 of 9 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$0-100.0%$-116,000-$-23,634,000-
2024$41.1M+13.9%$41.1M100.0%$-8,269,000-20.1%
2023$36.1M+129.0%$36.1M100.0%$-14,522,000-40.2%
2022$15.8M-$15.8M100.0%$-62,076,000-393.9%
2021$0-$0-$-37,786,000-
2020$0-$-45,000-$-29,548,000-
2019$0-$-23,000-$-26,727,000-
2018$0-$-6,102-$-8,615,000-
2017$0-$-122-$-1,712,050-

What if you invested $1,000 in EQ back in 2017?

Total return with dividends reinvested · 9+ years of data

Calculate Returns

How much would $100/month in EQ be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is EQ Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

EQ vs LLY — which is the better buy?

Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.

Compare Now

EQ — Frequently Asked Questions

Quick answers to the most common questions about buying EQ stock.

Is EQ's revenue growth accelerating or slowing?

EQ TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.

What is EQ's revenue history from 2017 to 2026?

Equillium, Inc. (EQ) revenue history spans 2017 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.

What is EQ's long-term revenue growth rate (CAGR)?

Equillium, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for EQ.

Why does EQ's quarterly revenue fluctuate?

EQ quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Equillium, Inc.'s revenue data from 2017 to 2026 shows full historical quarterly detail on this page.

How is EQ's revenue distributed by segment?

EQ reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.

How does EQ's revenue compare to industry peers?

Equillium, Inc. (EQ) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.